Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CDK12 inhibitors(cyclin dependent kinase 12 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HER2 Positive Breast Cancer | Preclinical | CN | 17 Feb 2023 | |
HER2 Positive Breast Cancer | Preclinical | CN | 17 Feb 2023 |